The current price of XTNT is $0.2894 — it has decreased by 3.53% since the previous close. Data as of Nov 6, 2026.
XTNT is down 12.30% over the past week, down 9.98% over the past month and down 61.55% over the past year. The price is below its 200-day moving average of $0.4525.
Analysts' average 12-month price target for XTNT is $1.00, which implies 245.54% upside from the current price. Individual estimates range from $1.00 to $1.00.
Xtant Medical Holdings, Inc. has a market capitalization of $40.6M. The company belongs to the Healthcare sector. Compare it with other companies in the stock screener.
In its most recent quarterly report, Xtant Medical Holdings, Inc. posted a loss of $0.07 per share against an estimate of -$0.02, missing expectations by 250.00%. Upcoming reports are listed in the earnings calendar.
Xtant Medical Holdings, Inc. reported revenue of $23.03M in its most recent quarter, which has decreased by 34.96% compared with the same quarter a year earlier. Analysts had expected $24.88M.
Companies most comparable to Xtant Medical Holdings, Inc. include Avita Medical Inc., Quipt Home Medical Corp., Apyx Medical Corporation, Fonar Corp. and Vivani Medical, Inc.
In the latest trading session XTNT moved between $0.2856 and $0.3072, a range of 7.46% of its current price.
Over the past 52 weeks XTNT has traded between $0.2702 and $0.84. The current price is 65.55% below its 52-week high.
Figures as of Nov 6, 2026. This information is provided for general purposes only and is not investment advice.